Lowry F. Kline - 03 May 2023 Form 4 Insider Report for DIXIE GROUP INC (DXYN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 May 2023, 15:48:34 UTC
Prior SEC filing
18 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John F. Henry, Jr., by Power of Attorney for Lowry F. Kline

Key filing fact

Lowry F. Kline filed Form 4 for DIXIE GROUP INC (DXYN) on 04 May 2023.

Key facts

  • This page summarizes Lowry F. Kline's Form 4 filing for DIXIE GROUP INC (DXYN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 May 2023, 15:48.

Change

  • Previous filing in this sequence was filed on 18 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXYN transaction

Common Stock, $3 par value

Award

Transaction value
$0
Shares
+8,000
Change %
+8.4%
Price
$0.000000
Shares after
102,699
Date
03 May 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Award of Restricted Stock in payment of the equity portion of non-employee director's annual retainer. Award vests five days after next year's annual meeting of shareholder.

Footnote F2

Includes 37,501 Performance Units, convertible into shares of Common Stock on retirement as a director and 41,198 shares held outright.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .